Kahl BS, Jegede OA, Peterson C, Swinnen LJ, et al. Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. J Clin Oncol 2024 Jan 9:JCO2301912. doi: 10.1200/JCO.23.01912.
PMID: 38194625